1. Adelaide Research & Scholarship
  2. Schools and Disciplines
  3. School of Paediatrics & Reproductive Health
  4. Paediatrics
  5. Paediatrics publications
Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7399
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumaratilake, L.-
dc.contributor.authorFerrante, A.-
dc.contributor.authorJaeger, T.-
dc.contributor.authorMorris-Jones, S.-
dc.date.issued1997-
dc.identifier.citationInfection and Immunity, 1997; 65(12):5342-5345-
dc.identifier.issn0019-9567-
dc.identifier.issn1098-5522-
dc.identifier.urihttp://hdl.handle.net/2440/7399-
dc.description.abstractKilling of Plasmodium falciparum blood forms by the differentiated human myelomonocytic THP-1Mo cell line was studied by a radiometric assay. Results showed that parasite killing was promoted by complement, antimalarial antibody, and the cytokines tumor necrosis factor alpha and gamma interferon. Differentiated THP-1Mo appears to be a useful monocytic cell line for the study of mechanisms of immunity to Plasmodium.-
dc.language.isoen-
dc.publisherAMER SOC MICROBIOLOGY-
dc.source.urihttp://dx.doi.org/10.1128/iai.65.12.5342-5345.1997-
dc.subjectMonocytes-
dc.subjectCell Line-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectPlasmodium falciparum-
dc.subjectMalaria, Falciparum-
dc.subjectTumor Necrosis Factor-alpha-
dc.subjectAntibodies, Protozoan-
dc.subjectCytotoxicity, Immunologic-
dc.subjectComplement System Proteins-
dc.titleThe Role of Complement, Antibody, and Tumor Necrosis Factor Alpha in the Killing of Plasmodium Falciparum By the Monocytic Cell Line THP-1-
dc.typeJournal article-
dc.identifier.doi10.1128/iai.65.12.5342-5345.1997-
pubs.publication-statusPublished-
dc.identifier.orcidFerrante, A. [0000-0002-2581-6407]-
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.